Related Experiment Video
Updated: May 10, 2026

Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals
Published on: March 30, 2017
Devices and formulations for pulmonary vaccination.
Wouter F Tonnis1, Anne J Lexmond, Henderik W Frijlink
1University of Groningen, Department of Pharmaceutical Technology and Biopharmacy , Antonius Deusinglaan 1, 9713 AV Groningen , The Netherlands w.f.tonnis@rug.nl.
Pulmonary vaccination offers a needle-free alternative, potentially enhancing immune responses against airborne diseases. Overcoming formulation and device challenges is key for widespread adoption in large-scale vaccination programs.
Area of Science:
- Pulmonary drug delivery
- Vaccine formulation
- Inhalation technology
Background:
- Pulmonary vaccination presents a needle-free alternative to traditional injection methods.
- It reduces risks associated with needle-stick injuries and healthcare worker burden.
- Local mucosal and systemic immune responses can be induced, improving efficacy against airborne pathogens.
Purpose of the Study:
- To review inhalation devices and formulation strategies for pulmonary vaccine administration.
- To identify critical parameters for assessing the feasibility and benefits of pulmonary vaccination.
- To guide the development of effective and accessible pulmonary vaccine systems.
Main Methods:
- Literature review of inhalation devices suitable for pulmonary vaccine delivery.
- Analysis of vaccine formulation strategies for lung administration.
- Discussion of critical parameters including target population and cost-effectiveness.
Main Results:
- Various inhalation devices and formulation strategies show potential for pulmonary vaccine delivery.
- Feasibility depends on factors like target population and specific vaccine characteristics.
- Challenges in pulmonary drug delivery and vaccine formulation remain.
Conclusions:
- A combined approach to inhalation device and vaccine formulation development is crucial.
- Systems must be user-friendly for the target population and cost-effective for mass production.
- Successful large-scale pulmonary vaccination requires overcoming current developmental hurdles.
Related Concept Videos
Inhaled Medications
Vaccinations
Vaccine Production
Vaccines
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

